Topical Cannabidiol for Treating Carpal Tunnel Syndrome - Trial NCT06108349
Access comprehensive clinical trial information for NCT06108349 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of Virginia and is currently Not yet recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Virginia
Timeline & Enrollment
Phase 2
Nov 01, 2023
Dec 01, 2024
Primary Outcome
Feasibility of CBD as a topical treatment for CTS is determined by the investigator by evaluating the Recruitment Rate, medication compliance rate and retention rate.
Summary
The Purpose of this study is to assess the safety and efficacy of Cannabidiol on treatment of
 Carpal Tunnel Syndrome.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06108349
Non-Device Trial